Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
26K
-
Shares change
-
+1.32K
-
Total reported value, excl. options
-
$112K
-
Value change
-
+$5.66K
-
Number of buys
-
1
-
Price
-
$4.29
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q4 2023
1 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q4 2023.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26K shares
of 84.7M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.82M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.78M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.47M shares), BVF INC/IL (3.35M shares), Rubric Capital Management LP (3.34M shares), VANGUARD GROUP INC (2.89M shares), FRANKLIN RESOURCES INC (2.76M shares), Kynam Capital Management, LP (2M shares), BAILLIE GIFFORD & CO (1.87M shares), and Samsara BioCapital, LLC (1.68M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.